Advertisement
Screener

Alexza Pharmaceuticals Inc. Operating Cash Flow

Alexza Pharmaceuticals Inc. Operating Cash Flow

Alexza Pharmaceuticals Inc. reported Operating Cash Flow of -$11.15 million for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-05.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2014-05-05

  • Alexza Pharmaceuticals Inc. net cash provided by (used in) operating activities for the quarter ending 2014-03-31 was -$11.15M.
  • Alexza Pharmaceuticals Inc. net cash provided by (used in) operating activities for the quarter ending 2013-12-31 was -$10.66M.
  • Alexza Pharmaceuticals Inc. net cash provided by (used in) operating activities for the quarter ending 2013-09-30 was -$9.96M.
  • Alexza Pharmaceuticals Inc. net cash provided by (used in) operating activities for the quarter ending 2013-06-30 was $29.13M.
  • Alexza Pharmaceuticals Inc. net cash provided by (used in) operating activities for fiscal 2013 was -$612.00K.
  • Alexza Pharmaceuticals Inc. net cash provided by (used in) operating activities for fiscal 2012 was -$18.24M.
  • Alexza Pharmaceuticals Inc. net cash provided by (used in) operating activities for fiscal 2011 was -$34.43M, a 500.68% decline from fiscal 2010.
  • Alexza Pharmaceuticals Inc. net cash provided by (used in) operating activities for fiscal 2010 was $8.59M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 126 monthNet Cash Provided by (Used in) Operating Activities 129 monthNet Cash Provided by (Used in) Operating Activities 132 monthNet Cash Provided by (Used in) Operating Activities 135 monthNet Cash Provided by (Used in) Operating Activities 138 monthNet Cash Provided by (Used in) Operating Activities 141 month
2014-03-31-$11.15M
10-Q · filed 2014-05-05
-$21.81M
derived: sum of 2 quarters · filed 2014-05-05
-$31.78M
derived: sum of 3 quarters · filed 2014-05-05
-$2.65M
derived: sum of 4 quarters · filed 2014-05-05
2013-12-31-$10.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-25
-$20.63M
derived: sum of 2 quarters · filed 2014-03-25
$8.50M
derived: sum of 3 quarters · filed 2014-03-25
-$612.00K
10-K · filed 2014-03-25
2013-09-30-$9.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06
$19.16M
derived: sum of 2 quarters · filed 2013-11-06
$10.05M
10-Q · filed 2013-11-06
$2.79M
derived: sum of 4 quarters · filed 2014-05-05
2013-06-30$29.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
$20.01M
10-Q · filed 2013-08-14
$12.76M
derived: sum of 3 quarters · filed 2014-05-05
$6.50M
derived: sum of 4 quarters · filed 2014-05-05
2013-03-31-$9.11M
10-Q · filed 2014-05-05
-$16.37M
derived: sum of 2 quarters · filed 2014-05-05
-$22.63M
derived: sum of 3 quarters · filed 2014-05-05
-$28.78M
derived: sum of 4 quarters · filed 2014-05-05
2012-12-31-$7.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-25
-$13.52M
derived: sum of 2 quarters · filed 2014-03-25
-$19.67M
derived: sum of 3 quarters · filed 2014-03-25
-$18.24M
10-K · filed 2014-03-25
2012-09-30-$6.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06
-$12.41M
derived: sum of 2 quarters · filed 2013-11-06
-$10.99M
10-Q · filed 2013-11-06
-$20.83M
derived: sum of 4 quarters · filed 2014-03-25
-$274.63M
10-Q · filed 2012-11-06
2012-06-30-$6.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
-$4.73M
10-Q · filed 2013-08-14
-$14.57M
derived: sum of 3 quarters · filed 2014-03-25
-$23.21M
derived: sum of 4 quarters · filed 2014-03-25
-$268.37M
10-Q · filed 2012-08-08
2012-03-31$1.43M
10-Q · filed 2013-05-14
-$8.42M
derived: sum of 2 quarters · filed 2014-03-25
-$17.06M
derived: sum of 3 quarters · filed 2014-03-25
-$24.65M
derived: sum of 4 quarters · filed 2014-03-25
-$262.22M
10-Q · filed 2012-05-10
2011-12-31-$9.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-25
-$18.49M
derived: sum of 2 quarters · filed 2014-03-25
-$26.08M
derived: sum of 3 quarters · filed 2014-03-25
-$34.43M
10-K · filed 2014-03-25
-$263.64M
10-K · filed 2012-03-12
2011-09-30-$8.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06
-$16.23M
derived: sum of 2 quarters · filed 2012-11-06
-$24.58M
10-Q · filed 2012-11-06
-$34.78M
derived: sum of 4 quarters · filed 2013-03-26
-$253.80M
10-Q · filed 2011-11-07
2011-06-30-$7.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08
-$15.94M
10-Q · filed 2012-08-08
-$26.14M
derived: sum of 3 quarters · filed 2013-03-26
-$30.49M
derived: sum of 4 quarters · filed 2013-03-26
-$245.16M
10-Q · filed 2011-08-08
2011-03-31-$8.35M
10-Q · filed 2012-05-10
-$18.55M
derived: sum of 2 quarters · filed 2013-03-26
-$22.90M
derived: sum of 3 quarters · filed 2013-03-26
2010-12-31-$10.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-26
-$14.55M
derived: sum of 2 quarters · filed 2013-03-26
$8.59M
10-K · filed 2013-03-26
2010-09-30-$4.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07
$18.80M
10-Q · filed 2011-11-07
2010-06-30$23.14M
10-Q · filed 2011-08-08
2009-12-31-$53.15M
10-K · filed 2012-03-12